{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:34:25Z","timestamp":1793223265375,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-01935-y","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T10:23:16Z","timestamp":1744885396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Sarcopenia in type 2 Diabetes mellitus among Asian populations: prevalence and risk factors based on AWGS- 2019: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"M.","family":"Yogesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohankumar","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushal Naranbhai","family":"Kidecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"issue":"Suppl 1","key":"1935_CR1","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.2337\/dc14-S081","volume":"37","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl 1):S81\u201390. https:\/\/doi.org\/10.2337\/dc14-S081.","journal-title":"Diabetes Care"},{"issue":"3","key":"1935_CR2","doi-asserted-by":"publisher","first-page":"472","DOI":"10.2337\/dc15-1536","volume":"39","author":"A Nanditha","year":"2016","unstructured":"Nanditha A, Ma RC, Ramachandran A, et al. Diabetes in Asia and the Pacific: Implications for the Global Epidemic. Diabetes Care. 2016;39(3):472\u201385. https:\/\/doi.org\/10.2337\/dc15-1536.","journal-title":"Diabetes Care"},{"issue":"1","key":"1935_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169.","journal-title":"Age Ageing"},{"issue":"3","key":"1935_CR4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"LK Chen","year":"2020","unstructured":"Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300-307.e2. https:\/\/doi.org\/10.1016\/j.jamda.2019.12.012.","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"1935_CR5","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.2337\/dc06-2537","volume":"30","author":"SW Park","year":"2007","unstructured":"Park SW, Goodpaster BH, Strotmeyer ES, et al. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care. 2007;30(6):1507\u201312. https:\/\/doi.org\/10.2337\/dc06-2537.","journal-title":"Diabetes Care"},{"key":"1935_CR6","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2147\/DMSO.S186600","volume":"12","author":"J Mesinovic","year":"2019","unstructured":"Mesinovic J, Zengin A, De Courten B, et al. Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. Diabetes Metab Syndr Obes. 2019;12:1057\u201372. https:\/\/doi.org\/10.2147\/DMSO.S186600.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"7","key":"1935_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.5694\/mja16.00446","volume":"205","author":"D Scott","year":"2016","unstructured":"Scott D, de Courten B, Ebeling PR. Sarcopenia: a potential cause and consequence of type 2 diabetes in Australia\u2019s ageing population? Med J Aust. 2016;205(7):329\u201333. https:\/\/doi.org\/10.5694\/mja16.00446.","journal-title":"Med J Aust"},{"key":"1935_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"1935_CR9","doi-asserted-by":"publisher","unstructured":"Moola S, Munn Z, Sears K, et al. Conducting systematic reviews of association (etiology): The Joanna Briggs Institute's approach. Int J Evid Based Healthc. 2015;13(3):163\u2013169. https:\/\/doi.org\/10.1097\/XEB.0000000000000064.","DOI":"10.1097\/XEB.0000000000000064"},{"key":"1935_CR10","doi-asserted-by":"publisher","unstructured":"Moher D, Liberati A, Tetzlaff J, et al. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097","DOI":"10.1371\/journal.pmed.1000097"},{"issue":"7109","key":"1935_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334. https:\/\/doi.org\/10.1136\/bmj.315.7109.629.","journal-title":"BMJ"},{"issue":"2","key":"1935_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341x.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455\u201363. https:\/\/doi.org\/10.1111\/j.0006-341x.2000.00455.x.","journal-title":"Biometrics"},{"key":"1935_CR13","doi-asserted-by":"publisher","first-page":"111415","DOI":"10.1016\/j.nut.2021.111415","volume":"91\u201392","author":"S Xiu","year":"2021","unstructured":"Xiu S, Sun L, Mu Z, et al. Low prealbumin levels are associated with sarcopenia in older men with type 2 diabetes mellitus: A cross-sectional study. Nutrition. 2021;91\u201392:111415. https:\/\/doi.org\/10.1016\/j.nut.2021.111415.","journal-title":"Nutrition"},{"issue":"7","key":"1935_CR14","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1507\/endocrj.EJ20-0655","volume":"68","author":"F Takahashi","year":"2021","unstructured":"Takahashi F, Hashimoto Y, Kaji A, et al. Sarcopenic obesity is associated with macroalbuminuria in patients with type 2 diabetes: a cross-sectional study. Endocr J. 2021;68(7):781\u20139. https:\/\/doi.org\/10.1507\/endocrj.EJ20-0655.","journal-title":"Endocr J"},{"key":"1935_CR15","doi-asserted-by":"publisher","unstructured":"Takahashi F, Hashimoto Y, Kaji A, et al. Sarcopenia Is Associated With a Risk of Mortality in People With Type 2 Diabetes Mellitus.\u00a0Front Endocrinol (Lausanne). 2021;12:783363. Published 2021. https:\/\/doi.org\/10.3389\/fendo.2021.783363","DOI":"10.3389\/fendo.2021.783363"},{"issue":"4","key":"1935_CR16","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jamda.2020.11.003","volume":"22","author":"K Sugimoto","year":"2021","unstructured":"Sugimoto K, Ikegami H, Takata Y, et al. Glycemic Control and Insulin Improve Muscle Mass and Gait Speed in Type 2 Diabetes: The MUSCLES-DM Study. J Am Med Dir Assoc. 2021;22(4):834-838.e1. https:\/\/doi.org\/10.1016\/j.jamda.2020.11.003.","journal-title":"J Am Med Dir Assoc"},{"key":"1935_CR17","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.clnesp.2021.08.039","volume":"46","author":"VV Sundar","year":"2021","unstructured":"Sundar VV, Ong SH, Easaw MEPM, et al. Sarcopenia with coexistent type 2 diabetes mellitus is associated with worse clinical outcomes among hospitalized cardiac patients. Clin Nutr ESPEN. 2021;46:380\u20135. https:\/\/doi.org\/10.1016\/j.clnesp.2021.08.039.","journal-title":"Clin Nutr ESPEN"},{"issue":"11","key":"1935_CR18","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1111\/jdi.13581","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Liu J, Zhang Q, et al. Elevated serum pentosidine is independently associated with the high prevalence of sarcopenia in Chinese middle-aged and elderly men with type 2 diabetes mellitus. J Diabetes Investig. 2021;12(11):2054\u201361. https:\/\/doi.org\/10.1111\/jdi.13581.","journal-title":"J Diabetes Investig"},{"key":"1935_CR19","doi-asserted-by":"publisher","unstructured":"Takahashi F, Hashimoto Y, Kaji A, et al. Association between Geriatric Nutrition Risk Index and The Presence of Sarcopenia in People with Type 2 Diabetes Mellitus: A Cross-Sectional Study.\u00a0Nutrients. 2021;13(11):3729. Published 2021 Oct 22. https:\/\/doi.org\/10.3390\/nu13113729","DOI":"10.3390\/nu13113729"},{"issue":"6","key":"1935_CR20","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/jdi.13436","volume":"12","author":"H Mori","year":"2021","unstructured":"Mori H, Kuroda A, Yoshida S, et al. High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: Findings from the Impact of Diabetes Mellitus on Dynapenia study. J Diabetes Investig. 2021;12(6):1050\u20139. https:\/\/doi.org\/10.1111\/jdi.13436.","journal-title":"J Diabetes Investig"},{"issue":"8","key":"1935_CR21","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/jdi.13788","volume":"13","author":"K Mikura","year":"2022","unstructured":"Mikura K, Kodama E, Iida T, et al. Association between sarcopenia and the severity of diabetic polyneuropathy assessed by nerve conduction studies in Japanese patients with type 2 diabetes mellitus. J Diabetes Investig. 2022;13(8):1357\u201365. https:\/\/doi.org\/10.1111\/jdi.13788.","journal-title":"J Diabetes Investig"},{"key":"1935_CR22","doi-asserted-by":"publisher","unstructured":"Hashimoto Y, Takahashi F, Kaji A, et al. Eating Speed Is Associated with the Presence of Sarcopenia in Older Patients with Type 2 Diabetes: A Cross-Sectional Study of the KAMOGAWA-DM Cohort.\u00a0Nutrients. 2022;14(4):759. Published 2022 Feb 11. https:\/\/doi.org\/10.3390\/nu14040759","DOI":"10.3390\/nu14040759"},{"issue":"11","key":"1935_CR23","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1111\/jdi.13882","volume":"13","author":"Y Hiromine","year":"2022","unstructured":"Hiromine Y, Noso S, Rakugi H, et al. Poor glycemic control rather than types of diabetes is a risk factor for sarcopenia in diabetes mellitus: The MUSCLES-DM study. J Diabetes Investig. 2022;13(11):1881\u20138. https:\/\/doi.org\/10.1111\/jdi.13882.","journal-title":"J Diabetes Investig"},{"key":"1935_CR24","doi-asserted-by":"publisher","unstructured":"Wang K, Zhang D, Cao G, et al. A Low Free T3 to Free T4 Ratio Is Associated with Sarcopenia in Euthyroid Patients with Type 2 Diabetes Mellitus.\u00a0J Diabetes Res. 2022;2022:2305156. Published 2022 Aug 17. https:\/\/doi.org\/10.1155\/2022\/2305156","DOI":"10.1155\/2022\/2305156"},{"key":"1935_CR25","doi-asserted-by":"publisher","unstructured":"Sayani, Das. The impact of diabetes on sarcopenia in community-dwelling older adults in India: key findings from the longitudinal ageing study in India (LASI). Diabetes epidemiology and management, (2023).100158\u2013100158. https:\/\/doi.org\/10.1016\/j.deman.2023.100158","DOI":"10.1016\/j.deman.2023.100158"},{"key":"1935_CR26","doi-asserted-by":"publisher","unstructured":"Chen MJ, Leng J, Ni JP, et al. U-shaped association between plasma C-peptide and sarcopenia: A cross-sectional study of elderly Chinese patients with diabetes mellitus.\u00a0PLoS One. 2023;18(10):e0292654. Published 2023 Oct 20. https:\/\/doi.org\/10.1371\/journal.pone.0292654","DOI":"10.1371\/journal.pone.0292654"},{"issue":"5","key":"1935_CR27","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.26355\/eurrev_202303_31557","volume":"27","author":"GC Ma","year":"2023","unstructured":"Ma GC, Zou LL, Dai W, et al. The association between glucose fluctuation with sarcopenia in elderly patients with type 2 diabetes mellitus. Eur Rev Med Pharmacol Sci. 2023;27(5):1912\u201320. https:\/\/doi.org\/10.26355\/eurrev_202303_31557.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1935_CR28","doi-asserted-by":"publisher","unstructured":"Takahashi F, Hashimoto Y, Okada H, et al. Dental care and oral conditions are associated with the prevalence of sarcopenia in people with type 2 diabetes: a cross-sectional study.\u00a0BMC Endocr Disord. 2023;23(1):76. Published 2023 Apr 7. https:\/\/doi.org\/10.1186\/s12902-023-01331-4","DOI":"10.1186\/s12902-023-01331-4"},{"key":"1935_CR29","doi-asserted-by":"publisher","unstructured":"Kim M, Kobori T. Association of a Combination of Sarcopenia and Type 2 Diabetes with Blood Parameters, Nutrient Intake, and Physical Activity: A Nationwide Population-Based Study.\u00a0Nutrients. 2023;15(23):4955. Published 2023 Nov 29. https:\/\/doi.org\/10.3390\/nu15234955","DOI":"10.3390\/nu15234955"},{"key":"1935_CR30","doi-asserted-by":"publisher","unstructured":"Lu L, Liu B, Yin F. Alternative skeletal muscle index for sarcopenia diagnosis in elderly patients with type 2 diabetes mellitus: A pilot study.\u00a0Front Endocrinol (Lausanne). 2023;14:1083722. Published 2023 Feb 9. https:\/\/doi.org\/10.3389\/fendo.2023.1083722","DOI":"10.3389\/fendo.2023.1083722"},{"issue":"12","key":"1935_CR31","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1111\/jdi.14078","volume":"14","author":"L Fu","year":"2023","unstructured":"Fu L, Zhang Q, Liu J, et al. Decreased serum musclin concentration is independently associated with the high prevalence of sarcopenia in Chinese middle-elderly patients with type 2 diabetes mellitus. J Diabetes Investig. 2023;14(12):1412\u20138. https:\/\/doi.org\/10.1111\/jdi.14078.","journal-title":"J Diabetes Investig"},{"key":"1935_CR32","doi-asserted-by":"publisher","unstructured":"Lu L, Liu B, Ma Y. Association of Different Obesity Phenotypes with Sarcopenia in Han Chinese Middle-Aged and Elderly with Type 2 Diabetes Individuals.\u00a0Diabetes Metab Syndr Obes. 2023;16:841\u2013848. Published 2023 Mar 21. https:\/\/doi.org\/10.2147\/DMSO.S398475","DOI":"10.2147\/DMSO.S398475"},{"key":"1935_CR33","doi-asserted-by":"publisher","unstructured":"Hsu YT, Lin JY, Lin CJ, et al. Association of Possible Sarcopenia or Sarcopenia with Body Composition, Nutritional Intakes, Serum Vitamin D Levels, and Physical Activity among Patients with Type 2 Diabetes Mellitus in Taiwan.\u00a0Nutrients. 2023;15(18):3892. Published 2023 Sep 7. https:\/\/doi.org\/10.3390\/nu15183892","DOI":"10.3390\/nu15183892"},{"key":"1935_CR34","doi-asserted-by":"publisher","unstructured":"Sravya SL, Swain J, Sahoo AK, et al. Sarcopenia in Type 2 Diabetes Mellitus: Study of the Modifiable Risk Factors Involved.\u00a0J Clin Med. 2023;12(17):5499. Published 2023 Aug 24. https:\/\/doi.org\/10.3390\/jcm12175499","DOI":"10.3390\/jcm12175499"},{"issue":"4","key":"1935_CR35","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/nhs.13055","volume":"25","author":"HY Yen","year":"2023","unstructured":"Yen HY, Lee SC, Lin CF, et al. Prevalence of sarcopenia and its association with diet and physical activity in older adults with type 2 diabetes: A cross-sectional study. Nurs Health Sci. 2023;25(4):628\u201335. https:\/\/doi.org\/10.1111\/nhs.13055.","journal-title":"Nurs Health Sci"},{"key":"1935_CR36","doi-asserted-by":"publisher","unstructured":"Lin Y, Zhong S, Sun Z. Association between serum triglyceride to high-density lipoprotein cholesterol ratio and sarcopenia among elderly patients with diabetes: a secondary data analysis of the China Health and Retirement Longitudinal Study.\u00a0BMJ Open. 2023;13(8):e075311. Published 2023 Aug 31. https:\/\/doi.org\/10.1136\/bmjopen-2023-075311","DOI":"10.1136\/bmjopen-2023-075311"},{"key":"1935_CR37","doi-asserted-by":"publisher","unstructured":"Wei W, Xie C, Cao R, et al. Ultrasound Assessment of the Gastrocnemius Muscle as a Potential Tool for Identifying Sarcopenia in Patients with Type 2 Diabetes.\u00a0Diabetes Metab Syndr Obes. 2023;16:3435\u20133444. Published 2023 Oct 30. https:\/\/doi.org\/10.2147\/DMSO.S435517","DOI":"10.2147\/DMSO.S435517"},{"key":"1935_CR38","doi-asserted-by":"publisher","unstructured":"Sun L, Fu J, Mu Z, et al. Association between body fat and sarcopenia in older adults with type 2 diabetes mellitus: A cross-sectional study.\u00a0Front Endocrinol (Lausanne). 2023;14:1094075. Published 2023 Jan 27. https:\/\/doi.org\/10.3389\/fendo.2023.1094075","DOI":"10.3389\/fendo.2023.1094075"},{"key":"1935_CR39","doi-asserted-by":"publisher","unstructured":"Xu K, Feng X, Xu Z, et al. Association of sarcopenia with osteoporosis in Chinese patients with type 2 diabetes.\u00a0BMC Musculoskelet Disord. 2024;25(1):226. Published 2024. https:\/\/doi.org\/10.1186\/s12891-024-07323-2","DOI":"10.1186\/s12891-024-07323-2"},{"key":"1935_CR40","doi-asserted-by":"publisher","unstructured":"Ji CH, Huang XQ, Li Y, et al. The Relationship between physical activity, nutritional status, and sarcopenia in community- dwelling older adults with type 2 diabetes: a cross-sectional study.\u00a0BMC Geriatr. 2024;24(1):506. Published 2024 Jun 7. https:\/\/doi.org\/10.1186\/s12877-024-05038-6","DOI":"10.1186\/s12877-024-05038-6"},{"issue":"1","key":"1935_CR41","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4103\/ijem.ijem_321_23","volume":"28","author":"M Yogesh","year":"2024","unstructured":"Yogesh M, Mody M, Makwana N, et al. The Hidden Battle Within: Shedding Light on the Coexistence of Sarcopenia and Sarcopenic Obesity among Participants with Type 2 Diabetes in a Tertiary Care Hospital. Gujarat Indian J Endocrinol Metab. 2024;28(1):80\u20135. https:\/\/doi.org\/10.4103\/ijem.ijem_321_23.","journal-title":"Gujarat Indian J Endocrinol Metab"},{"key":"1935_CR42","doi-asserted-by":"publisher","unstructured":"Zou M, Shao Z. Construction and evaluation of sarcopenia risk prediction model for patients with diabetes: a study based on the China health and retirement longitudinal study (CHARLS). Diabetol Metab Syndr. 2024;16(1):230. Published 2024 Sep 16. https:\/\/doi.org\/10.1186\/s13098-024-01467-w","DOI":"10.1186\/s13098-024-01467-w"},{"key":"1935_CR43","doi-asserted-by":"publisher","unstructured":"Kim S, Kim S, Hong KH. Association of Combining Diet and Physical Activity on Sarcopenia and Obesity in Elderly Koreans with Diabetes.\u00a0Nutrients. 2024;16(7):964. Published 2024 Mar 27. https:\/\/doi.org\/10.3390\/nu16070964","DOI":"10.3390\/nu16070964"},{"key":"1935_CR44","doi-asserted-by":"publisher","unstructured":"Sun Y, Liu BW, Zhang X, et al. Relationships Between the Apolipoprotein Levels and Sarcopenia in Inpatients with Type 2 Diabetes Mellitus: A Cross-Sectional Study.\u00a0Diabetes Metab Syndr Obes. 2024;17:2085\u20132094. Published 2024 May 20. https:\/\/doi.org\/10.2147\/DMSO.S461324","DOI":"10.2147\/DMSO.S461324"},{"key":"1935_CR45","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13018-024-04717-9","volume":"19","author":"L Quan","year":"2024","unstructured":"Quan L, Zhang F, Xu J, et al. Relationship between sarcopenia and fatty liver in middle-aged and elderly patients with type 2 diabetes mellitus. J Orthop Surg Res. 2024;19:250. https:\/\/doi.org\/10.1186\/s13018-024-04717-9.","journal-title":"J Orthop Surg Res"},{"key":"1935_CR46","doi-asserted-by":"publisher","unstructured":"M Y, Patel MG, Makwana HH, et al. Unravelling the enigma of sarcopenia and sarcopenic obesity in Indian adults with type 2 diabetes - a comparative cross-sectional study.\u00a0Clin Diabetes Endocrinol. 2024;10(1):22. Published 2024 Jun 17. https:\/\/doi.org\/10.1186\/s40842-024-00179-4","DOI":"10.1186\/s40842-024-00179-4"},{"key":"1935_CR47","doi-asserted-by":"publisher","unstructured":"Ida S, Imataka K, Morii S, et al. Frequency and Overlap of Cachexia, Malnutrition, and Sarcopenia in Elderly Patients with Diabetes Mellitus: A Study Using AWGC, GLIM, and AWGS2019.\u00a0Nutrients. 2024;16(2):236. Published 2024 Jan 11. https:\/\/doi.org\/10.3390\/nu16020236","DOI":"10.3390\/nu16020236"},{"issue":"10","key":"1935_CR48","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/jdi.14274","volume":"15","author":"M Sato","year":"2024","unstructured":"Sato M, Tamura Y, Murao Y, et al. Coexistence of high visceral fat area and sarcopenia is associated with atherosclerotic markers in old-old patients with diabetes: A cross-sectional study. J Diabetes Investig. 2024;15(10):1510\u20138. https:\/\/doi.org\/10.1111\/jdi.14274.","journal-title":"J Diabetes Investig"},{"key":"1935_CR49","doi-asserted-by":"publisher","unstructured":"Hou B, Wei X, Yang M, et al. Importance of Assessing Sarcopenia in Patients with Type 2 Diabetes Mellitus Based on Body Fat Percentage Measured by Dual-Energy X-ray absorptiometry in Different Genders.\u00a0Diabetes Metab Syndr Obes. 2024;17:2571\u20132581. Published 2024 Jun 25. https:\/\/doi.org\/10.2147\/DMSO.S461748","DOI":"10.2147\/DMSO.S461748"},{"key":"1935_CR50","doi-asserted-by":"publisher","unstructured":"Pal R, Prasad TN, Bhadada SK, et al. Association between bone microarchitecture and sarcopenia in postmenopausal women with type 2 diabetes.\u00a0Arch Osteoporos. 2024;19(1):94. Published 2024 Oct 4. https:\/\/doi.org\/10.1007\/s11657-024-01450-y","DOI":"10.1007\/s11657-024-01450-y"},{"key":"1935_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-024-01504-5","author":"S Zou","year":"2024","unstructured":"Zou S, Xiao T, Liu M, et al. Evaluating the prevalence and risk factors for sarcopenia in elderly patients with type 2 diabetes mellitus in a Chinese hospital setting. J Diabetes Metab Disord. 2024. https:\/\/doi.org\/10.1007\/s40200-024-01504-5.","journal-title":"J Diabetes Metab Disord"},{"issue":"5","key":"1935_CR52","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1210\/clinem\/dgab884","volume":"107","author":"L Feng","year":"2022","unstructured":"Feng L, Gao Q, Hu K, et al. Prevalence and Risk Factors of Sarcopenia in Patients With Diabetes: A Meta-analysis. J Clin Endocrinol Metab. 2022;107(5):1470\u201383. https:\/\/doi.org\/10.1210\/clinem\/dgab884.","journal-title":"J Clin Endocrinol Metab"},{"key":"1935_CR53","doi-asserted-by":"publisher","unstructured":"Ai Y, Xu R, Liu L. The prevalence and risk factors of sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.\u00a0Diabetol Metab Syndr. 2021;13(1):93. Published 2021 Sep 3. https:\/\/doi.org\/10.1186\/s13098-021-00707-7","DOI":"10.1186\/s13098-021-00707-7"},{"key":"1935_CR54","doi-asserted-by":"publisher","unstructured":"Shafiee G, Keshtkar A, Soltani A, et al. Prevalence of sarcopenia in the world: a systematic review and meta-analysis of general population studies.\u00a0J Diabetes Metab Disord. 2017;16:21. Published 2017 May 16. https:\/\/doi.org\/10.1186\/s40200-017-0302-x","DOI":"10.1186\/s40200-017-0302-x"},{"key":"1935_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155533","volume":"144","author":"S Yuan","year":"2023","unstructured":"Yuan S, Larsson SC. Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism. 2023;144: 155533. https:\/\/doi.org\/10.1016\/j.metabol.2023.155533.","journal-title":"Metabolism"},{"issue":"6","key":"1935_CR56","doi-asserted-by":"publisher","first-page":"103043","DOI":"10.1016\/j.arcmed.2024.103043","volume":"55","author":"E Amini-Salehi","year":"2024","unstructured":"Amini-Salehi E, Letafatkar N, Norouzi N, et al. Global Prevalence of Nonalcoholic Fatty Liver Disease: An Updated Review Meta-Analysis comprising a Population of 78 million from 38 Countries. Arch Med Res. 2024;55(6):103043. https:\/\/doi.org\/10.1016\/j.arcmed.2024.103043.","journal-title":"Arch Med Res"},{"key":"1935_CR57","doi-asserted-by":"publisher","unstructured":"Beaudart C, Rizzoli R, Bruy\u00e8re O, et al. Sarcopenia: burden and challenges for public health.\u00a0Arch Public Health. 2014;72(1):45. Published 2014 Dec 18. https:\/\/doi.org\/10.1186\/2049-3258-72-45","DOI":"10.1186\/2049-3258-72-45"},{"key":"1935_CR58","doi-asserted-by":"publisher","unstructured":"Carvalho do Nascimento PR, Bilodeau M, Poitras S. How do we define and measure sarcopenia? A meta-analysis of observational studies.\u00a0Age Ageing. 2021;50(6):1906\u20131913. https:\/\/doi.org\/10.1093\/ageing\/afab148","DOI":"10.1093\/ageing\/afab148"},{"key":"1935_CR59","doi-asserted-by":"publisher","unstructured":"Lisco G, Disoteo OE, De Tullio A, et al. Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age.\u00a0Nutrients. 2023;16(1):63. Published 2023 Dec 25. https:\/\/doi.org\/10.3390\/nu16010063","DOI":"10.3390\/nu16010063"},{"key":"1935_CR60","doi-asserted-by":"publisher","unstructured":"Tan NC, Sankari U, Ng CE, et al. A longitudinal study on the progression of muscle status among community-dwelling ambulatory older multiethnic Asians with type 2 diabetes mellitus.\u00a0BMC Geriatr. 2022;22(1):446. Published 2022 May 21. https:\/\/doi.org\/10.1186\/s12877-022-03098-0","DOI":"10.1186\/s12877-022-03098-0"},{"key":"1935_CR61","doi-asserted-by":"publisher","unstructured":"Izzo A, Massimino E, Riccardi G, et al. A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors.\u00a0Nutrients. 2021;13(1):183. Published 2021 Jan 9. https:\/\/doi.org\/10.3390\/nu13010183","DOI":"10.3390\/nu13010183"},{"key":"1935_CR62","doi-asserted-by":"publisher","unstructured":"Toba A, Ishikawa J. Sarcopenia as a risk factor for hypertension.\u00a0Hypertens Res. Published online September 19, 2024. https:\/\/doi.org\/10.1038\/s41440-024-01898-y","DOI":"10.1038\/s41440-024-01898-y"},{"issue":"5","key":"1935_CR63","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4239\/wjd.v14.i5.565","volume":"14","author":"ST Lim","year":"2023","unstructured":"Lim ST, Kang S. Exercise therapy for sarcopenia and diabetes. World J Diabetes. 2023;14(5):565\u201372. https:\/\/doi.org\/10.4239\/wjd.v14.i5.565.","journal-title":"World J Diabetes"},{"key":"1935_CR64","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12902-024-01722-1","volume":"24","author":"H Shatila","year":"2024","unstructured":"Shatila H, Ghazal N, Bukshaisha G, et al. Risk and determinants of sarcopenia in people with diabetes: a case\u2013control study from the Qatar Biobank cohort. BMC Endocr Disord. 2024;24:205. https:\/\/doi.org\/10.1186\/s12902-024-01722-1.","journal-title":"BMC Endocr Disord"},{"key":"1935_CR65","doi-asserted-by":"publisher","unstructured":"Landi F, Calvani R, Tosato M, et al. Protein Intake and Muscle Health in Old Age: From Biological Plausibility to Clinical Evidence.\u00a0Nutrients. 2016;8(5):295. Published 2016 May 14. https:\/\/doi.org\/10.3390\/nu8050295","DOI":"10.3390\/nu8050295"},{"issue":"8","key":"1935_CR66","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1007\/s40279-022-01675-2","volume":"52","author":"SJ O'Bryan","year":"2022","unstructured":"O\u2019Bryan SJ, Giuliano C, Woessner MN, et al. Progressive Resistance Training for Concomitant Increases in Muscle Strength and Bone Mineral Density in Older Adults: A Systematic Review and Meta-Analysis. Sports Med. 2022;52(8):1939\u201360. https:\/\/doi.org\/10.1007\/s40279-022-01675-2.","journal-title":"Sports Med"},{"key":"1935_CR67","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.jad.2020.05.076","volume":"274","author":"H Li","year":"2020","unstructured":"Li H, Chen J, Xu G, et al. The Effect of Tai Chi for Improving Sleep Quality: A Systematic Review and Meta-analysis. J Affect Disord. 2020;274:1102\u201312. https:\/\/doi.org\/10.1016\/j.jad.2020.05.076.","journal-title":"J Affect Disord"},{"issue":"1","key":"1935_CR68","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jcsm.12783","volume":"13","author":"F Petermann-Rocha","year":"2022","unstructured":"Petermann-Rocha F, Balntzi V, Gray SR, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022;13(1):86\u201399. https:\/\/doi.org\/10.1002\/jcsm.12783.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"1935_CR69","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/dom.15321","volume":"26","author":"W Tack","year":"2024","unstructured":"Tack W, De Cock AM, Dirinck EL, et al. Pathophysiological interactions between sarcopenia and type 2 diabetes: A two-way street influencing diagnosis and therapeutic options. Diabetes Obes Metab. 2024;26(2):407\u201316. https:\/\/doi.org\/10.1111\/dom.15321.","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"1935_CR70","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.jdiacomp.2017.05.003","volume":"31","author":"AJ Sinclair","year":"2017","unstructured":"Sinclair AJ, Abdelhafiz AH, Rodr\u00edguez-Ma\u00f1as L. Frailty and sarcopenia - newly emerging and high impact complications of diabetes. J Diabetes Complications. 2017;31(9):1465\u201373. https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.05.003.","journal-title":"J Diabetes Complications"},{"key":"1935_CR71","doi-asserted-by":"publisher","unstructured":"Jung CH, Cho YY, Choi DH, et al. Low muscle strength rather than low muscle mass is associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes.\u00a0Sci Rep. 2024;14(1):23385. Published 2024 Oct 8. https:\/\/doi.org\/10.1038\/s41598-024-74390-9","DOI":"10.1038\/s41598-024-74390-9"},{"issue":"1","key":"1935_CR72","doi-asserted-by":"publisher","first-page":"69","DOI":"10.15605\/jafes.039.01.03","volume":"39","author":"FB Rivera","year":"2024","unstructured":"Rivera FB, Escolano BT, Nifas FM, et al. Interrelationship of Sarcopenia and Cardiovascular Diseases: A Review of Potential Mechanisms and Management. J ASEAN Fed Endocr Soc. 2024;39(1):69\u201378. https:\/\/doi.org\/10.15605\/jafes.039.01.03.","journal-title":"J ASEAN Fed Endocr Soc"},{"issue":"6","key":"1935_CR73","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/nutrit\/nuad086","volume":"82","author":"E Amini-Salehi","year":"2024","unstructured":"Amini-Salehi E, Hassanipour S, Keivanlou MH, et al. The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis. Nutr Rev. 2024;82(6):815\u201330. https:\/\/doi.org\/10.1093\/nutrit\/nuad086.","journal-title":"Nutr Rev"},{"issue":"6","key":"1935_CR74","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/jcsm.12784","volume":"12","author":"C Liu","year":"2021","unstructured":"Liu C, Cheung WH, Li J, et al. Understanding the gut microbiota and sarcopenia: a systematic review. J Cachexia Sarcopenia Muscle. 2021;12(6):1393\u2013407. https:\/\/doi.org\/10.1002\/jcsm.12784.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"11","key":"1935_CR75","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.14670\/HH-18-730","volume":"39","author":"S Das","year":"2024","unstructured":"Das S, Preethi B, Kushwaha S, et al. Therapeutic strategies to modulate gut microbial health: Approaches for sarcopenia management. Histol Histopathol. 2024;39(11):1395\u2013425. https:\/\/doi.org\/10.14670\/HH-18-730.","journal-title":"Histol Histopathol"},{"key":"1935_CR76","doi-asserted-by":"publisher","unstructured":"Zhou J, Liu J, Lin Q, et al. Characteristics of the gut microbiome and metabolic profile in elderly patients with sarcopenia.\u00a0Front Pharmacol. 2023;14:1279448. Published 2023. https:\/\/doi.org\/10.3389\/fphar.2023.1279448","DOI":"10.3389\/fphar.2023.1279448"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-01935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-01935-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-01935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T10:23:17Z","timestamp":1744885397000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-01935-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1935"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-01935-y","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}